Researchers Map Tau Modifications Across Tauopathies
Boston Children's Hospital researchers led by Judith A. Steen and Hanno Steen analyzed brain tissue from 203 patients across multiple tauopathies using FLEXITau mass spectrometry to absolutely quantify 145 post‑translational modifications and 195 cleavage sites. Machine‑learning models ranked disease‑discriminant molecular features, producing a validated molecular atlas that aims to guide precision diagnostics, imaging, and therapeutic target selection across tau-mediated neurodegeneration.
Key Points
- 1Quantify 145 post-translational tau modifications and 195 cleavage sites across 203 patient brains
- 2Reveal disease-specific chemical signatures implicating distinct enzymatic writer and eraser pathways across tauopathies
- 3Enable prioritized diagnostic and therapeutic targets via FLEXITau quantitation and machine-learning feature ranking
Scoring Rationale
Strong quantitative atlas and validation provide actionable targets, limited mainly by disease heterogeneity and translational steps.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
